Cerebral Vascular Stent Market

Drivers

• Rising prevalence of cerebral vascular diseases

According to the American Association of Neurological Surgeons (AANS), stroke, carotid stenosis, vertebral stenosis &intracranial stenosis, aneurysms, and vascular malformations are some cerebrovascular diseases caused by the restricted blood flow to the brain. Blood artery constriction (stenosis), clot development (thrombosis), blockage (embolism), and blood vessel rupture can all cause blood flow restrictions (hemorrhage). Ischemia (lack of blood supply to the brain) damages brain tissue and can lead to a stroke.

According to the World Stroke Organization (WSO)’s Global Stroke Fact Sheet 2019, 13 million new cases of stroke are diagnosed globally every year, and over 80 million people have experienced stroke currently living.  According to the report, one in four people will experience a stroke in their lifetime. Cerebral vascular stents are placed appropriately to improve blood flow in the brain and treat or prevent strokes from happening. Therefore, the high prevalence of cerebral disorders is likely to drive the cerebral vascular stent market significantly.

• Rising geriatric population

Even though cerebrovascular disorders can occur at any age, from infants to old age people, the risk of getting such a disorder increases with age. Aging causes vascular morphological and functional changes in the brain, making it more vulnerable to cerebrovascular disorders.According to a report published by Mayo Clinic, the US, in May 2019, the most powerful non-modifiable risk factor for incident stroke is aging, and the risk doubles every ten years after the age of 55. Around three-quarters of all strokes occur in those over the age of 65.

The frequency of incident strokes in older persons is likely to increase with the growing population crossing 65 years of age.

According to a report published by United Nations (UN) in December 2020, the older population is growing rapidly due to factors such as increasing levels of life expectancy and decreasing fertility levels; about 727 million peopleaged 65 years or over were living in 2020, and this number is projected to increase to 1.5 billion approximately in 2050. Globally, the population aged 65 years or over is expected to increase from 9.3 per cent in 2020 to around 16.0 per cent in 2050.Hence, the increasing geriatric population will supplement the growth of the cerebral vascular stent market.

Opportunities

• Increasing clinical trials and approvals for cerebral vascular stents

The increase in the number of clinical trials for cerebral vascular stents is expected to significantly boost cerebral vascular stent market growth when the regulatory bodies approve the products. Several products are also getting expanded indication approvals. For instance, Stryker’s (US) Neuroform Atlas received expanded indication from the FDAfor use in the posterior circulation applications in the brain.

Several recent product approvals further supplement the cerebral vascular stent market growth. For instance, the Pipeline Flex Embolization Device, by Micro Therapeutics, Inc. (US), a product for treating brain aneurysms, was approved by the FDA in December 2018. FDA approved another product called Neuroform Atlas Stent System by Stryker (US) in May 2019. Furthermore, In December 2019, FRED System, a stent product by MicroVention, Inc. (US), was also approved by FDA for brain aneurysm treatment.

Restraints

• Post-surgery complications for cerebral vascular stents

Some of the common issues that can occur during the procedure include an arterial puncture, stent movement, injury to the arterial lining resulting in an arterial dissection, bleeding into the brain, and stroke due to artery obstruction.According to National Heart Lung and Blood Institute, one to two percent of people who undergo stent surgery develop a blood clot at the stent site. However, the benefits of using stents outweigh the risks associated.

Value Chain Analysis

The cerebral vascular stent market is growing steadily due to the rising number of players coming forward with new and better products. The value chain analysis of the cerebral vascular stent market comprises five major components starting with the research & development and designing, followed by manufacturing the products, distribution & sales, and post-sales services. 

Research and development start with conceptualizing, followed by design, then development, and lastly, testing. The R&D segment comprises 25-30% of the value chain. After the product designs are final, the manufacturing of the product starts. Manufacturing consists of 45-50% of the value chain.The manufacturing components are sometimes outsourced. Outsourcing eliminates manufacturing process activities of some parts and helps to quicker the process. Then comes distribution and sales, which is essential for any industry. Here, awareness about the products is spread across the market to attain interested customers for the product. It consists of 10-15% of the value chain.

And lastly comes post-sales services. The post-marketing monitoring stage begins with a periodic safety update report of the product, which is to be submitted to the FDA after the device comes into the market and accounts for around 5% of the value chain. In this step, sometimes product recalls also occur if some long-term issues related to the products are discovered. For instance, in March 2020, FDA recalled Pipeline Flex brain stent products of Medtronic plc (Ireland),citing fracture reports during the implantation procedure.

The Global Cerebral Vascular Stent Market Industry is projected to experience substantial growth over the coming years. With an estimated market value of 0.45 USD Billion in 2024, the industry is on track to reach 1.1 USD Billion by 2035. This growth trajectory, characterized by a CAGR of 8.44% from 2025 to 2035, indicates a robust demand for cerebral vascular stents driven by various factors, including technological advancements, increasing incidence of cerebrovascular diseases, and supportive government initiatives. The market's expansion reflects the ongoing commitment to improving patient care and outcomes in the field of cerebrovascular health.

Growing awareness and education regarding cerebrovascular diseases are influencing the Global Cerebral Vascular Stent Market Industry. Public health campaigns and educational programs are increasingly informing patients and healthcare professionals about the risks and symptoms of cerebrovascular conditions. This heightened awareness is likely to lead to earlier diagnosis and treatment, increasing the demand for cerebral vascular stents. As patients become more informed about their treatment options, healthcare providers are encouraged to adopt advanced stenting technologies. This trend is expected to contribute to the overall market growth, aligning with the projected increase in market value.

The aging population globally is a significant driver of the Global Cerebral Vascular Stent Market Industry. As individuals age, the risk of cerebrovascular diseases escalates, leading to a higher demand for effective treatment options. The World Health Organization projects that the number of people aged 60 years and older will double from 12 percent to 22 percent of the global population by 2050. This demographic shift underscores the necessity for cerebral vascular stents, as healthcare systems adapt to meet the needs of an older population. Consequently, the market is poised for growth as healthcare providers seek to address this pressing health challenge.

Government initiatives aimed at improving healthcare infrastructure and funding for cerebrovascular disease treatments are propelling the Global Cerebral Vascular Stent Market Industry. Various countries are implementing policies to enhance access to advanced medical technologies, including cerebral vascular stents. Increased funding for research and development in this field is likely to yield innovative solutions that address the complexities of cerebrovascular diseases. As a result, the market is expected to grow at a CAGR of 8.44% from 2025 to 2035, reflecting the positive impact of governmental support on the availability and accessibility of these critical medical devices.

Innovations in stent technology are driving the Global Cerebral Vascular Stent Market Industry forward. Recent advancements include the development of bioresorbable stents and drug-eluting stents, which enhance patient safety and efficacy. These technologies aim to reduce complications associated with traditional stents, such as thrombosis and restenosis. As healthcare providers increasingly adopt these advanced devices, the market is likely to witness substantial growth. The anticipated market value of 1.1 USD Billion by 2035 suggests a robust trajectory fueled by continuous innovation and improved patient outcomes.

The Global Cerebral Vascular Stent Market Industry is experiencing growth due to the increasing prevalence of cerebrovascular diseases, such as stroke and transient ischemic attacks. Statistics indicate that stroke remains a leading cause of mortality and morbidity worldwide, with millions affected annually. This rising incidence necessitates advanced treatment options, including cerebral vascular stents, to improve patient outcomes. As healthcare systems prioritize effective interventions, the demand for stents is projected to rise significantly. The market is expected to reach 0.45 USD Billion in 2024, reflecting the urgent need for innovative solutions in managing cerebrovascular conditions.